Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase InhibitorAntonia F. Stepan, Christopher J. O’Donnell, Ashley Robshaw et al.|Journal of Medicinal Chemistry|2012Cited by 460
Metabolism-Directed Design of Oxetane-Containing Arylsulfonamide Derivatives as γ-Secretase InhibitorsAntonia F. Stepan, R. Scott Obach, Kapil Karki et al.|Journal of Medicinal Chemistry|2011Cited by 106
Quantitative Pharmacokinetic/Pharmacodynamic Analyses Suggest That the 129/SVE Mouse Is a Suitable Preclinical Pharmacology Model for Identifying Small-Molecule γ-Secretase InhibitorsYasong Lu, David Riddell, Liming Zhang et al.|Journal of Pharmacology and Experimental Therapeutics|2011Cited by 24
SAR and chemistry of Aurora kinase inhibitors: Discovery of PF-3814735, an oral clinical candidateSamit K. Bhattacharya, Xumiao Zhao, Donn G. Wishka et al.|Cancer Research|2008Cited by 5
P1–109: Inhibition of BACE1 reduces beta‐amyloid 1–40 but not N‐terminal‐truncated beta‐amyloidKevin Atchison, David Riddell, Claude Ambroise et al.|Alzheimer s & Dementia|2013Cited by 0